|
Tilley, B C; Pillemer, S R; Heyse, S P et al. (1999) Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. Arthritis Rheum 42:1879-88
|
|
Alarcon, G S; Tilley, B C; Li, S et al. (1999) Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA. J Rheumatol 26:1065-7
|
|
Bluhm, G B; Sharp, J T; Tilley, B C et al. (1997) Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol 24:1295-302
|
|
Tuttleman, M; Pillemer, S R; Tilley, B C et al. (1997) A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol 24:1910-5
|
|
Pillemer, S R; Fowler, S E; Tilley, B C et al. (1997) Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum 40:419-25
|
|
Reveille, J D; Alarcon, G S; Fowler, S E et al. (1996) HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum 39:1802-7
|
|
Tilley, B C; Alarcon, G S; Heyse, S P et al. (1995) Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med 122:81-9
|
